Correlating preoperative gastroduodenoscopy findings with elevated tumor markers (CEA: 9.69 ng/ml, NSE: 18.34 ng/ml), it was considered that this case represented synchronous primary cancers, involving both a pancreatic neuroendocrine tumor and early gastric cancer. The gene discussed is ENO2; the disease is gastric cancer.